Learn More
Medchemexpress LLC (4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)-4-pyridinyl]... | 1628805-46-8 | MFCD31630851 | 99.2% | 490.45 g·mol⁻¹ | C23H22F4N6O2 | 1 ML

Supplier: Medchemexpress LLC HY10403610MM 1ML
IDH-305 is an orally available, mutant-selective, brain-penetrant inhibitor of isocitrate dehydrogenase 1 (IDH1) that targets R132 mutations. It is provided for research use in biochemical and cellular assays and is supplied as a 10 mM solution in DMSO (1 mL) or as solid quantities.
- Potent, mutant-selective inhibition of IDH1 (R132).
- Brain-penetrant, enabling central nervous system studies.
- Supplied as 10 mM solution in DMSO and as solid packs for flexibility.
- High purity for research-grade applications.
- Defined storage conditions to preserve stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.